<DOC>
	<DOCNO>NCT00200941</DOCNO>
	<brief_summary>This study intend determine whether topiramate efficacious safe treatment restless legs syndrome .</brief_summary>
	<brief_title>Efficacy Safety Study Topiramate Treat Restless Legs Syndrome</brief_title>
	<detailed_description>Benzodiazepines , levo-dopa/carbidopa , dopamine agonist , anticonvulsant , opioids use variable success , treat RLS . Often , RLS patient treat benzodiazepine , course several month , develop tolerance medication . Also , benzodiazepine cause confusion daytime sleepiness may addictive . Patients may also develop tolerance levo-dopa/carbidopa treatment . Because short half-life , symptom may suppress first part sleep period recur later night . Rebound report . Worse yet , augmentation , occurrence RLS symptom , often severe treatment begin , earlier day , may occur 80 % RLS patient treat levod-dopa/carbidopa . Dopamine agonist , include pergolide , pramipexole , ropinirole , effective patient others . Common side effect drug include coryza , hypotension , rash . Of anticonvulsant , preliminary report suggest gabapentin , carbamazepine , divalproex suppress RLS symptoms patient , especially mild RLS . Side effect include sleepiness , ataxia , weight gain . Opioid treatment RLS describe effective , aside stigma take controlled substance regularly , side effect may include nausea , sedation , constipation , dysequilibrium . Iron supplementation therapeutic patient iron deficiency RLS . Preliminary anecdotal data suggest topiramate reduces RLS symptom . Topiramate several potential mechanism action include enhancement GABA-mediated inhibition , may account observed benefit patient RLS . Topiramate may better alternative currently available treatment suppress RLS symptom . Like gabapentin , offer possibility decrease RLS symptom also diminish pain , especially patient limb pain neuropathy , radiculopathy , cause . Unlike gabapentin , topiramate may help overweight patient RLS lose weight , anedotal report weight reduction medication correct .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>The symptom subject must meet diagnostic criterion International RLS Study Group More five periodic leg movement per hour record baseline polysomnography ( PSG ) Each subject must discontinue treatment RLS agree take RLS treatment study Clinically unstable medical problem History nephrolithiasis Progressive neurologic disease Inadequate therapeutic response two previous treatment regimen RLS Subjects unable discontinue medication know cause suppress RLS Subjects sleep apnea syndrome Subjects consume daily three beverage contain caffeine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Actigraphy</keyword>
	<keyword>Polysomnography</keyword>
</DOC>